A new study published in the New England Journal of Medicine shows that cancer treatments do not harm unborn children. The researchers wrote, “Prenatal exposure to maternal cancer with or without treatment did not impair the cognitive, cardiac, or general development of children in early childhood. Prematurity was correlated with a worse cognitive outcome, but […]
In a study published today in the New England Journal of Medicine, a group of cancer researchers got a rare kind of result: one that was way, way better than they had expected. “We knew these patients were going to do well, but we didn’t dream they would do this well,” Joseph Sparano, the study’s lead author, told the Wall Street Journal.
A major study published in the New England Journal of Medicine is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
A new article in the prestigious New England Journal of Medicine offers guidance for doctors and other travelers about how to deal with medical emergencies during air travel. It's important advice that could save your life.
The editor of the New England Journal of Medicine took to its pages last week to castigate the Center for Medical Progress for picking on poor Planned Parenthood. Boo hoo. Jeffrey Drazen doesn’t rebut the tapes’ contents, just asserts PP is ethical–as if his and their claim make it so. But that brings up another issue. Show More Summary
A study, published in New England Journal of Medicine, describes the use of a new pacemaker that can be implanted into the heart without the necessity for surgery to test its safety and efficacy in fragile patients who require permanent pacing for normal functioning of the heart. Show More Summary
In this week's New England Journal of Medicine, researchers report results of a trial showing the efficacy of a new enzyme-replacement therapy for lysosomal acid lipase deficiency. In an accompanying editorial, Daniel J. Rader, MD, chair...Show More Summary
The New England Journal of Medicine is as much an ideological as a medical and science journal. Case in point, an angry tribute to Planned Parenthood by editor-in-chief Jeffrey M. Drazen and two other doctors (one, a volunteer for PP). Show More Summary
ROCHESTER, Minn. — Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a study published today in the New England Journal of Medicine. Journalists: Sounds bites with Dr. Tefferi are available in the download. "We observed that Imetelstat was active and induced morphologic […]
A recent commentary published in the New England Journal of Medicine (NEJM) by Philip J. Landrigan and Charles Benbrook has sparked some controversy. Landrigan and Benbrook are publishing in a medical journal because they claim the issue of genetically modified organisms (GMOs) is a public health issue. They use extremely strained logic and misrepresentation to [...]
There’s a piece in the New England Journal of Medicine written by Aaron Belkin, Ph.D. entitled Caring for Our Transgender Troops — The Negligible Cost of Transition-Related Care to convince Defense Secretary Ashton Carter to lift the ban on transgender military personnel. Doctor Belkin, Ph.D says that the military can easily afford to allow transgender […]
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Show More Summary
The New England Journal of Medicine, the most important medical periodical in the world, has a few bones to pick with the Republican Party’s would-be presidential candidates. In an editorial, the journals’ editors attack the stance held by most of the Republican hopefuls that Planned Parenthood should be defunded. A separate opinion piece argues that there is nothing wrong […]
Research coordinated by the ECOG-ACRIN Cancer Research Group and just published in the The New England Journal of Medicine, examines the outcomes of giving the chemotherapy drug docetaxel at the start of androgen deprivation therapy for patients with metastatic hormone-sensitive prostate cancer. Show More Summary
A new review article, published in the July 23, 2015 issue of The New England Journal of Medicine, analyzes the pros and cons of five different interventional approaches to gallbladder disease.
Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.
Source: Chronicle Augusta.com Mike Magee This week, Ted Kaptchuk and Franklin Miller published a seminal article in the New England Journal of Medicine titled, “Placebo Effects in Medicine”. I believe it will be remembered for many years,...Show More Summary
A study in the New England Journal of Medicine reports that taking daily shots of liraglutide (marketed as Saxenda) can help overweight or obese patients lose weight -- a lot of it. Patients taking the medication lost an average of more than 12 pounds, twice as much as those on a placebo, after 56 weeks.Read full article >>
The "placebo effect" is often described as events that occur when patients show improvement from treatments that contain no active ingredients. A "Perspectives" article in the July 2 issue of The New England Journal of Medicine proposes that placebo effects be more broadly defined to reflect their role as a valuable component of medical care.
As we recently discussed (here, here, here and here), in May, 2015, the New England Journal of Medicine, arguably the world's foremost medical journal, published an editorial and a three-part commentary arguing that current concerns about the effects of financial conflicts of interest (COI) on health care are overblown(1-4). Show More Summary